Compare ESOA & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESOA | OVID |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.2M | 117.5M |
| IPO Year | 2006 | 2017 |
| Metric | ESOA | OVID |
|---|---|---|
| Price | $9.24 | $1.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $21.00 | $3.50 |
| AVG Volume (30 Days) | 136.0K | ★ 1.6M |
| Earning Date | 02-11-2026 | 03-10-2026 |
| Dividend Yield | ★ 1.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $411,001,373.00 | $6,610,000.00 |
| Revenue This Year | $4.11 | $1,077.56 |
| Revenue Next Year | $5.24 | N/A |
| P/E Ratio | $411.98 | ★ N/A |
| Revenue Growth | 16.80 | ★ 945.89 |
| 52 Week Low | $7.64 | $0.24 |
| 52 Week High | $12.14 | $2.01 |
| Indicator | ESOA | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 59.30 | 45.09 |
| Support Level | $8.62 | $1.50 |
| Resistance Level | $9.60 | $1.61 |
| Average True Range (ATR) | 0.44 | 0.11 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 75.17 | 23.08 |
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.